Who owns the EXACNE trademark?

The EXACNE trademark is owned by DERMA RESEARCH GROUP, INC..

What class is the EXACNE trademark registered in?

The EXACNE trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for EXACNE?

The USPTO serial number for EXACNE is 88024957.

What is the registration number for EXACNE?

EXACNE is registered under USPTO registration number 6153836.

Sealvo

Home Search: EXACNEEXACNE #88024957

Back

Updated Sep 27, 2026·42 searches this week

View on USPTO TSDR Find similar marks

EXA

USPTO Trademark Record

REGISTERED

EXACNE

SN 88024957·Reg 6153836·Filed Jul 03, 2018

Owner DERMA RESEARCH GROUP, INC.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

EXACNE (Serial No. 88024957), Registration No. 6153836, is a registered US trademark filed on Jul 03, 2018 by DERMA RESEARCH GROUP, INC.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

renewal grace 6y period: March 15, 2027168 days remaining

Conflict Analysis

Full conflict analysis for EXACNE (SN 88024957) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

EXACNE (Reg. #6153836) is a registered US trademark that has been protecting its owner, DERMA RESEARCH GROUP, INC., since 2018. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jul 03, 2018

SERIAL

88024957

REG#

6153836

REGISTERED

Sep 15, 2020

Filing Information

StatusREGISTERED

Filing DateJul 03, 2018

Serial Number88024957

Registration No.6153836

Registration DateSep 15, 2020

Status DateSep 15, 2020

Published for OppositionMay 28, 2019

Filing Basis & Declarations

Standard Characters ClaimedFiled as Use ApplicationUse Application CurrentlyTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

First use anywhere: Jul 21, 2020

First use in commerce: Jul 21, 2020

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

29 events

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Sep 15, 2025

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

REGISTERED-PRINCIPAL REGISTER

Sep 15, 2020

REGISTERED-PRINCIPAL REGISTER

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Aug 11, 2020

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Aug 10, 2020

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Aug 05, 2020

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Aug 05, 2020

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Jul 22, 2020

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Jul 22, 2020

USE AMENDMENT FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jan 22, 2020

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Jan 20, 2020

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Jan 20, 2020

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Jan 20, 2020

SOU EXTENSION 1 GRANTED

ASSIGNED TO EXAMINER

Sep 30, 2019

ASSIGNED TO EXAMINER

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jul 23, 2019

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 28, 2019

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

PUBLISHED FOR OPPOSITION

May 28, 2019

PUBLISHED FOR OPPOSITION

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 08, 2019

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

LAW OFFICE PUBLICATION REVIEW COMPLETED

Apr 24, 2019

LAW OFFICE PUBLICATION REVIEW COMPLETED

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 23, 2019

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO LIE

Apr 19, 2019

ASSIGNED TO LIE

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 19, 2019

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 19, 2019

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 11, 2019

TEAS RESPONSE TO OFFICE ACTION RECEIVED

NON-FINAL ACTION WRITTEN

Oct 22, 2018

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Oct 22, 2018

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Oct 22, 2018

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Oct 21, 2018

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 09, 2018

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jul 06, 2018

NEW APPLICATION ENTERED

Other Marks by DERMA RESEARCH GROUP, INC.

Additional USPTO filings from the same owner.

GEN

GENOPLEX MICRODELIVERY ACTIVATOR

97350109

Derma Research Group, Inc.

REGISTERED

GMA

GMA7

97350104

Derma Research Group, Inc.

REGISTERED

PRO

PROTECTIF

97350095

Derma Research Group, Inc.

REGISTERED

SAJ

SAJIC

97349531

Derma Research Group, Inc.

REGISTERED

Other Marks by Szymon Gurda

Additional USPTO filings handled by the same attorney of record.

DES

DESTINATION WELLNESS

98778284

REGISTERED

WOL

WOLSKA

79425592

REGISTERED

DEA

DEAD ON TOOLS

99611638

REGISTERED

BRA

BRANDOLLARS

90697290

REGISTERED

EXACNE

Run a conflict check

Other Marks by DERMA RESEARCH GROUP, INC.

Other Marks by Szymon Gurda

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company